Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
Authors
Keywords
-
Journal
CURRENT OPINION IN INFECTIOUS DISEASES
Volume 24, Issue 6, Pages 545-553
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-15
DOI
10.1097/qco.0b013e32834cf054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies
- (2011) Yong Chong et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Antibiotics and antibiotic-resistant bacteria in waters associated with a hospital in Ujjain, India
- (2010) Vishal Diwan et al. BMC PUBLIC HEALTH
- Perils of quinolone exposure in cancer patients
- (2010) Gopi Rangaraj et al. CANCER
- Optimal Use of Fluoroquinolones in the Intensive Care Unit Setting
- (2010) John C. Rotschafer et al. CRITICAL CARE CLINICS
- Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective
- (2010) Esther Shu-Ting Ng et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Fluoroquinolone prophylaxis: a word of caution
- (2010) Senthil Lingaratnam et al. LEUKEMIA & LYMPHOMA
- Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance
- (2010) Esther Shu-Ting Ng et al. LEUKEMIA & LYMPHOMA
- Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
- (2010) John B. Bossaer et al. SUPPORTIVE CARE IN CANCER
- Prevention of febrile neutropenia: use of prophylactic antibiotics
- (2009) M Cullen et al. BRITISH JOURNAL OF CANCER
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
- High incidence of methicillin-resistantStaphylococcus aureussepsis and death in patients with febrile neutropenia at Royal Darwin Hospital
- (2009) INTERNAL MEDICINE JOURNAL
- Extended-spectrum β-lactamase-producing organisms
- (2009) M.E. Falagas et al. JOURNAL OF HOSPITAL INFECTION
- Increasing extended-spectrum β-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: Data from the Smart Study 2002–2006
- (2009) Wen-Chien Ko et al. JOURNAL OF INFECTION
- Neutropenic Fever Syndromes in Patients Undergoing Cytotoxic Therapy for Acute Leukemia and Myelodysplastic Syndromes
- (2009) E.J. Bow SEMINARS IN HEMATOLOGY
- Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia coli Isolates
- (2008) Luke Johnson et al. AMERICAN JOURNAL OF MEDICINE
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution
- (2008) C. Cattaneo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started